BGMD - BG Medicine Inc.

BGMD valuation $36.48 million

Stock Price

1.06
Change: ↓ -0.02 (-1.8519%)
Last Update: 2015-01-30T16:15:14-05:00
Shares Outstanding: 34,417,249
Industry: Medical Diagnostics & Research

BG Medicine, Inc., the developer of the BGM Galectin-3 Test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders.

Stock Price Data

Open: 1.09 Previous Close: 1.08
High: 1.22 Low: 0.97
Bid: 1.01 Ask: 1.04

Bid Size: 2600 Ask Size: 1200
Raw Bid Size: 26 Raw Ask Size: 12
Trade Volume: 3642 Share Volume: 2889455
Last Trade Date: 2015-01-30 Last Trade Time: 16:00:00-05:00
Vwap: 1.119423912 EPS: -0.27

Fundamental Data

PE ratio: PB ratio: 21.20
Beta: 2.077708

52 Week High: 2.419 52 Week Low: 0.27
52 Week High Vwap: 2.1998 52 Week Low Vwap: 0.2758
52 Week High Volume: 17569415 52 Week Low Volume: 32031
52 Week Avg Volume: 682046
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
GENE Genetic Technologies Ltd Sponsored ADR 2.79
PKI PerkinElmer Inc. 45.67
A Agilent Technologies Inc. 37.77
TMO Thermo Fisher Scientific 125.29
APPY Venaxis Inc. 0.51
DGX Quest Diagnostics Inc. 71.15
CPHD CEPHEID 56.46
QGEN Qiagen N.V. 22.93
OXFD Oxford Immunotec Global PLC 11.76
AFFX Affymetrix Inc. 11.04